Ventripoint Medical System Plus (VMS+) 4.0

The Ventripoint Medical System Plus (VMS+) 4.0 is a Class II medical device designed as an adjunct to existing ultrasound imaging systems for computerized 3-dimensional image processing. It leverages a Knowledge-Based Reconstruction algorithm to generate accurate 3D heart models and derive volumes and ejection fractions for all four cardiac chambers from 2D ultrasound data.

Ventripoint Diagnostics Ltd.'s Ventripoint Medical System Plus (VMS+) 4.0 has achieved substantial equivalence to a legally marketed device, allowing its marketing as a Class II Medical Image Management and Processing System. This regulatory determination permits the device to be placed into interstate commerce, provided it complies with general controls such as annual registration, device listing, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. The VMS+ 4.0 system functions as an adjunct to existing ultrasound imaging systems, designed to record, analyze, store, and retrieve digital ultrasound images for computerized 3-dimensional image processing. It is specifically indicated for use when volumes and ejection fractions of the Left Ventricle, Right Ventricle, Left Atrium, and Right Atrium are required, operating by employing a Knowledge-Based Reconstruction algorithm to generate 3D heart models from 2D ultrasound data. Comprehensive testing, including software verification and validation, electrical safety, electromagnetic compatibility, user validation, and cybersecurity assessments, has confirmed the device's intended performance and safety.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the Knowledge-Based Reconstruction algorithm's accuracy for 3D heart models compare to other established methods, especially in challenging echocardiographic windows?; What specific clinical advantages does the VMS+ 4.0 offer over conventional 2D echocardiography for assessing cardiac chamber volumes and ejection fractions?; Are there specific patient populations or cardiac pathologies where the VMS+ 4.0 system demonstrates superior diagnostic utility or improved workflow efficiency?; What are the cybersecurity protocols and data privacy measures implemented within the VMS+ 4.0 system to protect sensitive patient information?; Can the VMS+ 4.0 system be integrated with picture archiving and communication systems (PACS) or electronic health records (EHR) for seamless data transfer and clinical decision support?